发酵马铃薯蛋白制备ACE抑制肽

从市售腐乳和酸菜中筛选出12株产蛋白酶菌株,然后用筛选出的菌株来发酵马铃薯蛋白,测定其蛋白酶活力对菌株进行复筛。通过测定发酵液的水解度和ACE抑制率得到一株最适合发酵马铃薯蛋白制备ACE抑制肽的菌株4-2-1。结果表明,用该菌株发酵马铃薯蛋白,其水解度和ACE抑制率分别为:(7.72±0.04)%和(86.94±0.78)%。     

益生菌发酵藜麦制备ACE抑制肽

目的:探究利用益生菌发酵藜麦制备血管紧张素转换酶(ACE)抑制发酵液潜在的能力及发酵工艺对其的影响。方法:以藜麦为原料,ACE抑制率为指标,对18株乳酸菌和12株酵母制备具有ACE抑制能力的发酵液进行了筛选,并对接种量、发酵温度、发酵时间进行了正交优化;对发酵液中的肽进行液质鉴定,并对筛选出的肽进行体内试验评价降压效果。结果:30株菌中Lactobacillus paracasei L2(副干酪乳杆菌)作用效果最好,发酵藜麦制备的发酵液ACE抑制率高达(86.50±0.25)%;Lactobacillus paracasei L2菌株发酵藜麦制备具有ACE抑制活性的发酵液最佳发酵条件为接种量5%,发酵时间48 h,发酵温度34℃,该条件下ACE抑制率最高,为(90.41±0.16)%;通过对液质鉴定结果比对数据库得到两条ACE抑制效果较好的两条肽NIFRPFAPEL和AALEAPRILNL,它们均能够在自发性高血压大鼠(SHR)体内显现出显著的降血压作用,均在灌胃4 h时达到最佳降压效果。收缩压(SBP)分别降低(2.67±0.21),(3.46±0.01) kPa,舒张压(DBP)分...     

具有高效ACE抑制活性乳酸菌的筛选及其益生特性研究

本研究运用紫外分光光度法初筛,再以HPLC法进行复筛,从31株源自云南传统发酵食品的乳酸菌中筛选具有高效ACE抑制活性菌株,同时研究其益生特性及脱脂乳发酵过程中ACE抑制率的动态变化。综合各项研究结果,最终筛选出ACE抑制率较高、抑菌谱广、耐酸耐胆盐性强,且对抗生素敏感的Lactobacillus plantarum YM-4-3作为研究菌株。益生特性研究表明,该菌株对Escherichia coli O 157:H 7和Listeria monocytogenes的抑菌圈直径可分别达41.30 mm和42.00 mm,甚至在高胆盐(0.3%)及强酸(p H 2.5)处理后仍保持较高活菌数(大于105 cfu数量级)。脱脂乳发酵过程中ACE抑制活性的动态监测表明,37℃发酵48 h是Lb.plantarum YM-4-3菌株发酵产生ACE抑制肽的最适培养条件,该发酵条件下获得的发酵乳的ACE抑制率可高达81.23%,菌体生物量、游离氨基酸及多肽含量也均达到最大值。本研究成果将为新型具有高效ACE抑制活性发酵乳制品的研发提供理论依据及菌株保证。     

大湘西野生猕猴桃酿酒酵母的分离鉴定及其产物ACE抑制活性

通过平板划线、显微镜观察、WL培养基筛选、酒精度及血管紧张素转化酶(Angiotensin converting enzyme,ACE)抑制活性测定,对野生猕猴桃酿酒酵母进行分离筛选,再利用26S rDNA D1/D2区序列分析进行分子生物学鉴定。利用该菌株对野生猕猴桃进行纯种发酵,研究不同发酵阶段中发酵醪液的ACE抑制率、酒精度及多肽浓度变化。结果表明,经分离筛选获得适于猕猴桃果酒发酵的野生酵母JM11为酿酒酵母(Saccharomyces cerevisiae),在发酵4 d时发酵醪液的ACE抑制率为(93. 0±2. 6)%,酒精度为(7. 8±0. 5)%Vol,多肽浓度为(2 652. 0±112. 4)μg/mL,说明该菌株可酿制果酒,制得的产品还具有良好的ACE抑制活性,可作为野生猕猴桃降血压型保健果酒发酵的专用菌种或选育野生猕猴桃专用菌种的出发菌株。     

微生物发酵法制备大豆ACE抑制肽菌种的筛选

以大豆分离蛋白为底物,以血管紧张素转化酶(ACE)抑制率和肽含量为检测指标,选择5株乳酸菌、3株霉菌和1株枯草芽孢杆菌为出发菌种,通过微生物发酵筛选出具有高ACE抑制活性的发酵菌株。结果表明:乳酸菌中具有强ACE抑制活性的菌株为保加利亚乳杆菌,ACE抑制率和肽含量分别为57.93%和3.27mg/mL;霉菌中具有强ACE抑制活性的菌株为米曲霉,ACE抑制率和肽含量分别为41.23%和2.17mg/mL;枯草芽孢杆菌ACE抑制率和肽含量分别为45.02%和2.25mg/mL。综合比较9种菌株的发酵特性,选用保加利亚乳杆菌作为制备大豆抗高血压活性肽优良菌株。     

具有血管紧张素转换酶抑制活性的乳酸菌筛选及特性研究

血管紧张素转换酶（Angiotensin Converting Enzyme，ACE）是抗高血压药物的筛选靶位酶。以体外ACE抑制率为筛选指标，从传统发酵食品中筛选出12株具有ACE抑制活性的乳酸菌，研究了12株乳酸菌的ACE抑制活性和蛋白水解活性，以及模拟胃肠消化对乳酸菌发酵乳ACE抑制活性的影响和乳酸菌耐酸耐胆汁的特性。结果表明，CZ2112具有良好ACE抑制活性，经API鉴定系统鉴定为植物乳杆菌，ACE抑制类型为非竞争性抑制，24h发酵产物ACE抑制率可以达到83％，经模拟胃肠消化后抑制率为70％，邻苯二甲醛（OPA）法检测其蛋白水解活性为OPA指数0．43，对胃酸、胆汁具有较好的耐受性。     

枸杞起泡酒发酵菌株的筛选及其功效研究

本研究以实验室保藏的8株酿酒酵母(Saccharomyces cerevisiae)为试验菌株,通过对比各株酵母菌生长发酵性能,考察其发酵风味的特异性,筛选出一株酿酒酵母(CGMCC 16558);以此菌株作为试验菌株,以枸杞汁为原料静置发酵得到枸杞起泡酒,对其进行功效探究:(1)通过体外抗氧化检测枸杞起泡酒的抗氧化作用,检测到枸杞汁发酵后对DPPH和ABTS自由基半抑制量分别提高了88.84%和72.25%;(2)探究枸杞起泡酒的降血脂作用,检测发现枸杞汁发酵后对高脂HepG2模型细胞的甘油三酯和胆固醇均有抑制效果,1%浓度下的枸杞汁和枸杞起泡酒对甘油三酯抑制率为18.54%和27.93%,对胆固醇抑制率为9.84%和7.10%;(3)通过体外检测枸杞汁发酵前后对ACE酶抑制作用考察其降血压能力,枸杞汁和枸杞起泡酒对ACE抑制率分别为39.9%和35.75%;(4)将枸杞发酵前后样品作用于人脐静脉内皮细胞,检测到添加10-15%枸杞起泡酒显著促进NO释放,推测枸杞起泡酒有助于预防和缓解冠心病的发生。     

响应面优化米曲霉固态发酵豆粕制备A C E抑制肽条件

以多肽得率和血管紧张素转化酶(Angiotensin I-converting enzyme,ACE)抑制率为指标,考察发酵时间、发酵温度、接种量和含水量单因素对米曲霉固态发酵豆粕制备ACE抑制肽的影响,确定发酵时间为60 h。在此基础上通过响应面分析法进行优化,得到最优发酵条件为:发酵温度30℃,接种量7%,含水量56%,该条件下ACE抑制率达到56.03%。     

具有血管紧张素转化酶抑制活性的益生菌筛选鉴定及其发酵特性的研究

目的 筛选具有血管紧张素转化酶(ACE)抑制作用的微生物, 提供适用于降高血压发酵产品的菌株。方法 从7种发酵食品中分离菌株后, 利用体外ACE酶抑制率法筛选ACE抑制率大于80%的菌株, 再通过耐盐和耐NaNO2实验, 筛选出目的菌, 并对其进行生物学特性测定和分子生物学鉴定。结果 从发酵食品中分离得到98株菌中, 筛选出F2和D2两个目的菌, F2和D2的ACE酶抑制率分别为83.13%和98.00%, 且均能耐受6%的NaCl及100 mg/kg的NaNO2。结论 筛选出的F2菌株为地衣芽孢杆菌, 对金黄色葡萄球菌抑菌效果显著; D2为球形芽孢杆菌, 具有脂肪酶活性; 且F2和D2菌均具有蛋白酶活性。     

益生菌发酵制备金针菇血管紧张素转化酶抑制肽

为了获得高活性的金针菇血管紧张素转化酶（ACE）抑制肽,该研究对益生菌发酵制备金针菇ACE抑制肽的工艺条件进行了优化,并采用超滤法对ACE抑制肽进行了分级分离和活性鉴定。试验以ACE抑制率为评价指标,对枯草芽孢杆菌（Bacillus subtilis）、酿酒酵母（Saccharomyces cerevisiae）和黑曲霉（Aspergillus niger）三种益生菌进行了筛选,优选出沉淀分离活性肽的最适pH,然后采用单因素和响应面设计对发酵条件进行了考察。结果表明,确定枯草芽孢杆菌为最适菌种;沉淀ACE抑制肽的最适pH为6;最佳发酵条件为蒸馏水与金针菇粉液料比5∶1(mL∶g)、发酵时间16 h、发酵温度37℃、金针菇粉用量35 g/500 mL三角瓶,于此条件下ACE抑制率实测值为（51.25±1.02）%;截留分子质量<3 kDa的ACE抑制肽活性最强。     

发酵酸化技术对乳饼蛋白质降解及蛋白肽生物活性的影响

通过发酵酸化技术研制发酵型乳饼,以传统的直接酸化技术为对照,通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳（sodium dodecyl sulfate-polyacrylamide gel electrophoresis,SDS-PAGE）、液相色谱-质谱测定乳饼蛋白质降解情况和游离氨基酸含量,通过用液相色谱-串联质谱鉴定乳饼蛋白肽。并通过测定体外抗氧化活性、α-葡萄糖苷酶抑制率和血管紧张素转换酶（angiotensin-converting enzyme,ACE）抑制率表征乳饼蛋白肽的生物活性。SDS-PAGE结果表明,两种酸化技术均能促进乳饼蛋白质的降解,发酵酸化技术对乳清蛋白的降解程度更高,能促进游离氨基酸的释放。从发酵酸化乳饼中鉴定出潜在的ACE抑制肽23?条、抗氧化肽6?条和降糖肽5?条,而传统的直接酸化乳饼中分别为13、4?条和1?条。发酵酸化技术能显著提升乳饼蛋白肽的α-葡萄糖苷酶抑制活性和ACE抑制活性（P＜0.05）,其中分子质量＜3?kDa超滤组分对二者抑制率的IC50分别为1.250?mg/mL和0.416?mg/mL。发酵酸化技术能促进乳饼蛋白质降解,释放生物活性多肽,同时产生游离氨基酸,提升乳饼的生物学价值。     

锡盟蒙古族传统发酵马乳中功能性特征肽段的研究

乳基中的小分子活性肽的相关研究,近几年被重点关注,它可以提高机体免疫能力,是调节生理代谢的功能成分。发酵马乳已被证实具有较高的营养价值和医疗保健作用。该研究针对锡盟蒙古族传统发酵马乳,用高效凝胶过滤色谱与超高效液相色谱-电喷雾串联三重四极杆质谱分析发酵马乳样品中蛋白水解物的分子质量分布,并对主要的功能二肽进行定性定量检测。研究结果表明,发酵后马乳的分子质量在1000 Da以下的蛋白水解物比例有显著提升,检测出24条具有潜在血管紧张素转化酶(angiotensin-converting enzyme,ACE)抑制功能的二肽,标记含量较高且有功能活性的肽段VP、AF为该发酵马乳样品的特征肽段,并对以上功能肽段的构效关系进行探讨。该研究为进一步开发来源于蒙古族传统发酵食品中的功能乳肽提供参考。     

发酵调味品中血管紧张素转化酶抑制肽的研究进展

发酵调味品是采用微生物发酵的方法,生产具有食品调味和佐餐功能的一类食品。因微生物发酵原料和菌种的不同,所产生的调味品功能有所差异,蛋白类原料在微生物酶的作用下,能够产生相对较多的血管紧张素转化酶（ACE）抑制肽。ACE抑制肽是一类能抑制血管紧张素调节酶活性的多肽物质,可以起到预防或治疗高血压的作用。该研究通过对目前发酵调味食品ACE抑制肽的来源、制备方法、分离纯化方法等进行了介绍,并分析了发酵调味品ACE抑制肽今后的研究发展方向和产业发展趋势。     

Yeasts from Colombian Kumis as source of peptides with Angiotensin I converting enzyme (ACE) inhibitory activity in milk

This study investigated the possibility of using yeast strains in fermented milks to obtain products with high Angiotensin I-converting enzyme (ACE) inhibitory activity and low bitter taste. Ninety-three yeast strains isolated from Colombian Kumis in different geographic regions were molecularly identified, and their milk fermentation performances were determined. Molecular identification evidenced that Galactomyces geotrichum, Pichia kudriavzevii, Clavispora lusitaniae and Candida tropicalis, were the dominant species. Eighteen out of 93 strains produced fermented milk with ACE-inhibitory (ACEI) activity values ranging from 8.69 to 88.19%. Digestion of fermented milk samples by pepsin and pancreatin demonstrated an increase in ACEI activity, with C. lusitaniae KL4A as the best producer of ACEI peptides. Moreover, sensory analysis of the products containing the major ACE-inhibitory activity pointed out that P. kudriavzevii KL84A and Kluyveromyces marxianus KL26A could be selected as potential adjunct starter cultures in Kumis, since they made a considerable contribution to the ACE inhibitory activity and produced fermented milk without bitter taste. In this study we observed that Colombian Kumis can be an excellent vehicle for the isolation of yeasts with a potential to enhance bioactive peptides produced during milk fermentation.     

产ACE抑制肽乳酸菌的筛选、益生特性评定及应用

目的:筛选出富产血管紧张素转化酶(Angiotensin converting enzyme,ACE)抑制肽的乳酸菌并评定其益生特性.方法:依据蛋白水解度及ACE抑制率对乳酸菌进行初筛,然后依据模拟胃肠消化后的ACE抑制率最终筛出2株乳酸菌ZJUIDS09和ZJUIDS11,进一步评价其耐酸、耐胆盐、抗生素耐药性和抑菌...     

Antidiabetic,angiotensin-converting enzyme inhibitory and anti-inflammatory activities of fermented camel milk and characterisation of novel bioactive peptides from lactic-fermented camel milk with molecular interaction study

This study was to separate and purify antidiabetic and angiotensin-converting enzyme (ACE) inhibitory peptides from Lactiplantibacillus plantarum KGL3A fermented camel milk. After 48 h of fermentation at 37°C, ɑ-amylase inhibition, ɑ-glucosidase inhibition, lipase inhibition and ACE inhibitory activities were 80.94%, 64.45%, 63.93%, and 77.53%, respectively in fermented camel milk. Optimisation of growth condition for the evaluation of maximum peptide production was evaluated by measuring proteolytic activity (O-phthalaldehyde, OPA method) with different inoculation rates and incubation times and highest proteolytic activity (9.21 mg/mL) was observed after 48 h of fermentation at 2.5% rate of inoculation. The antidiabetic and ACE inhibitory activity of 3 kDa permeate fraction were higher as compared with other fractions. Purification of antidiabetic and ACE inhibitory peptides from fermented camel milks was performed through sodium dodecyl-sulphate polyacrylamide gel electrophoresis, and 2-dimensional polyacrylamide gel electrophoresis and maximum number of protein bands were present in between 25 and 10 kDa. The generated peptide sequences were matched with antihypertensive peptide database (AHTPDB) and BIOPEP databases for confirming the antidiabetic and ACE inhibitory activity. Peptides, that is. TDVMPQWW and MMSLVSLLLVGILFPTIQAK were having highest peptide ranker score among the all sequences. Furthermore, anti-inflammatory activity (TNF-α, IL-6 and IL-1β) of fermented camel milk was evaluated in macrophage cell line RAW 264.7 (Ralph and William's cell line). Furthermore, peptides were predicted to have improved binding affinity against Human Angiotensin converting enzyme (hACE) through molecular docking.     

Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension

Fermented milk is a potential source of various biologically active peptides with specific health benefits. Angiotensin converting enzyme inhibitory (ACE-I) peptides are one of the most studied bioactive peptides produced during milk fermentation. The presence of these peptides is reported in various fermented milk products such as, yoghurt, cheese, sour milk, etc., which are also available as commercial products. Many of the ACE-I peptides formed during milk fermentation are resistant to gastrointestinal digestion and inhibit angiotensin converting enzyme (ACE) in the rennin angiotension system (RAS). There are various factors, which affect the formation ACE-I peptides and their ability to reach the target tissue in active form, which includes type of starters (lactic acid bacteria (LAB), yeast, etc.), substrate composition (casein type, whey protein, etc.), composition of ACE-I peptide, pre and post-fermentation treatments, and its stability during gastrointestinal digestion. The antihypertensive effect of fermented milk products has also been proved by various in vitro and in vivo (animal and human trials) experiments. This paper reviews the literature on fermented milk products as a source of ACE-I peptides and various factors affecting the production and activity of ACE-I peptides.     

基于LC-MS/MS的酸乳肽谱及ACE抑制活性

利用液相色谱-串联质谱(liquid chromatography-tandem mass spectrometry,LC-MS/MS)的方法,对4种酸乳(优味舒风味发酵乳、风味发酵乳、初乳24+K风味发酵乳和十天风味发酵乳)的肽谱进行分析,分别鉴定到152、125、364条和274条肽段。利用血管紧张素转换酶(angiotensin converting enzyme,ACE)的抑制活性比较以上4种酸乳的生物活性,在相同质量浓度2.0 mg/L时,4种酸乳ACE抑制率分别为46.84%、42.75%、77.41%和63.84%。初乳24+K风味发酵乳含有肽的数量大、ACE抑制活性高可能与其独特的原料成分相关。对4种酸乳的肽谱及ACE抑制活性的考察,为进一步研究酸乳肽的功能特点和ACE抑制活性提供了理论依据。     

Antihypertensive activity of casein-enriched milk fermented by Lactobacillus helveticus

Milk proteins contain peptidic angiotensin I-converting enzyme (ACE) inhibitors, which can be released by proteolysis during milk fermentation by some strains of Lactobacillus helveticus. Reconstituted milk media containing skim milk powder (12%), skim milk powder (10%) with added sodium caseinate (5%) or whey protein isolate (5%) were fermented by L. helveticus strains R211 and R389, and further tested for bacterial growth, proteolysis (free NH₃ groups) and ACE-inhibitory activity. The antihypertensive activity in spontaneously hypertensive rats (SHR) was also investigated with caseinate-enriched milk unfermented (UFM) and fermented by the two strains of L. helveticus. Caseinate-enriched milk fermented by both strains showed higher proteolysis and ACE-inhibitory activity, indicating that ACE-inhibitory peptides are probably released from caseins during milk fermentation. Significant decreases in mean arterial blood pressure in SHR rats were measured following oral administration of UFM milk at doses of 1.0 and 2.5 g kg⁻¹ of body weight, and milk fermented by R211 or R389 strains at doses of 0.5, 1.0 and 2.5 g kg⁻¹ of body weight. The antihypertensive activity of UFM could be explained by the release of ACE-inhibitory peptides from caseins during the digestion process.     

Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effect of fermented milk

Milk was fermented with a total of 25 lactic acid bacteria to assay in vitro inhibitory activity towards angiotensin I converting enzyme (ACE). The tested strains belonged to Lactobacillus acidophilus, Lactobacillus casei, Lacobacillus helveticus, Lactobacillus jensenii, Lactobacillus reuteri, Lactobacillus rhamnosus, Lactococcus lactis ssp. lactis, Lactococcus. raffinolactis and Leuconostoc mesenteroides ssp. cremoris. The ACE inhibitory potencies of theses strains varied and seven of them showing the highest ACE inhibitory activity were selected for further studies. The development of ACE inhibitory activity during fermentation correlated with degree of hydrolysis. Modification of fermentation conditions or pH control did not affect the ACE inhibitory activity. ACE inhibitory compounds from Lb. jensenii fermented milk were isolated by reversed phase HPLC and identified by MS-analysis and amino acid sequencing. The active compounds were peptides from β-casein. The milk fermented with Lb. jensenii caused a transient reduction of blood pressure in spontaneously hypertensive rats.